Liquidia Corporation Common Stock vs Sotera Health Company Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.49 (market cap $2.40B), while Sotera Health Company Common Stock trades at $17.68 (market cap $5.20B). The key difference: Sotera Health Company Common Stock is far larger — about 2.2× Liquidia Corporation Common Stock's market cap, and Sotera Health Company Common Stock is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Sotera Health Company Common Stock for 0 Days on average.
| LQDA | SHC | |
|---|---|---|
Market Cap | $2.40B | $5.20B |
Volume | 2,857,547 | 1,647,777 |
Sector | Health | Health |
52-Week High | $91.03 | $19.57 |
52-Week Low | $22.02 | $13.13 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.30B | $7.11B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Sotera Health Company is a US provider of sterilization and lab testing services for the healthcare industry, operating through its Sterigenics, Nordion, and Nelson Labs businesses.
Read more on SHC →